501
|
1472
|
1ea0A |
Alpha subunit of a. brasilense glutamate synthase |
70
|
244
|
5l5dB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
68
|
250
|
5l5dA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
69
|
243
|
5l5bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
69
|
242
|
5l5dD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
44
|
196
|
3uneJ |
Mouse constitutive 20s proteasome |
59
|
201
|
3unhK |
Mouse 20s immunoproteasome |
57
|
204
|
3tddI |
Crystal structure of yeast cp in complex with belactosin c |
71
|
212
|
3tddK |
Crystal structure of yeast cp in complex with belactosin c |
62
|
222
|
3tddH |
Crystal structure of yeast cp in complex with belactosin c |
61
|
198
|
3tddJ |
Crystal structure of yeast cp in complex with belactosin c |
64
|
212
|
1fntL |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
54
|
239
|
1fntD |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
53
|
247
|
1fntB |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
53
|
198
|
1fntK |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
54
|
204
|
1fntJ |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
62
|
240
|
1fntG |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
47
|
238
|
1fntA |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
64
|
233
|
1fntF |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
138
|
459
|
1ao0A |
Glutamine phosphoribosylpyrophosphate (prpp) amidotransferase from b. subtilis complexed with adp and gmp |
51
|
222
|
1fntI |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
59
|
244
|
1fntE |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
55
|
241
|
1fntC |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
56
|
222
|
1fntM |
Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator pa26 from trypanosome brucei at 3.2 angstroms resolution |
69
|
243
|
5m2bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
60
|
195
|
5m2bJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
62
|
241
|
5m2bG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
70
|
243
|
5l67F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
60
|
237
|
5lf0C |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
68
|
242
|
5l6aD |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
64
|
231
|
5m2bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
59
|
196
|
5l5wN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
64
|
244
|
5leyG |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
69
|
243
|
5l60F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
65
|
213
|
5lf0L |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
64
|
234
|
5le5E |
Native human 20s proteasome at 1.8 angstrom |
63
|
222
|
5l69L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
63
|
222
|
5l6cL |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
67
|
233
|
5l5yM |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
58
|
195
|
5l69J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
66
|
250
|
5l64A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
75
|
248
|
5lf3B |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
62
|
222
|
5lzpA |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
59
|
196
|
5l66N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
62
|
220
|
5lexH |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
61
|
220
|
5lf7H |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
55
|
204
|
5lezI |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
62
|
244
|
5lf1G |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
59
|
226
|
5l66H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
64
|
211
|
5l68K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |